Literature DB >> 29568089

The importance of bone marrow examination in patients with light chain amyloidosis achieving a complete response.

Surbhi Sidana1, Nidhi Tandon1, Angela Dispenzieri1, Morie A Gertz1, S Vincent Rajkumar1, Shaji K Kumar2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29568089     DOI： 10.1038/s41375-018-0022-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  When should treatment of AL amyloidosis start at relapse? Early, to prevent organ progression.

Authors:  Giovanni Palladini; Giampaolo Merlini
Journal:  Blood Adv       Date:  2019-01-22

2.  Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.

Authors:  Surbhi Sidana; Eli Muchtar; M Hasib Sidiqi; Dragan Jevremovic; Angela Dispenzieri; Wilson Gonsalves; Francis Buadi; Martha Q Lacy; Suzanne R Hayman; Taxiarchis Kourelis; Prashant Kapoor; Ronald S Go; Rahma Warsame; Nelson Leung; S Vincent Rajkumar; Robert A Kyle; Morie A Gertz; Shaji K Kumar
Journal:  Am J Hematol       Date:  2020-02-14       Impact factor: 10.047

Review 3.  Systemic amyloidosis: moving into the spotlight.

Authors:  Oliver C Cohen; Ashutosh D Wechalekar
Journal:  Leukemia       Date:  2020-04-09       Impact factor: 11.528

4.  Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis.

Authors:  M Hasib Sidiqi; Mohammed A Aljama; Dragan Jevremovic; Eli Muchtar; Francis K Buadi; Rahma Warsame; Martha Q Lacy; Angela Dispenzieri; David Dingli; Wilson I Gonsalves; Shaji Kumar; Prashant Kapoor; Taxiarchis Kourelis; Nelson Leung; William J Hogan; Morie A Gertz
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-30       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.